Background: The standard recommended treatment of stage IV gastric cancer is palliative chemotherapy. The aim of this study is to evaluate the role of radical gastrectomy with metastasectomy in these patients, as well as to explore the feasibility and safety of a laparoscopic approach.
Methods: 117 consecutive patients with pathologically proven Stage IV gastric cancer who underwent radical gastrectomy with metastasectomy were enrolled in this study. We evaluated short-term and long-term outcomes, comparing laparoscopic surgery with open surgery by propensity score matching.
Results: The 5-year overall survival rate (OSR) was 23.2% and the median survival time (MST) was 19.8 months. After propensity scoring matching, the 5-year OSR and MST of laparoscopy group was 23.4%, 17.9 months and in the open group, it was 25.0%, 22.8 months (p = 0.882). The complication rate was 5.6% in the laparoscopy group and 23.4% in the open group (p = 0.069). In multivariate analysis, adjuvant chemotherapy, chemotherapy cycle, and postoperative complication were independent prognostic factors of overall survival.
Conclusions: Radical gastrectomy with metastasectomy could have a potential role in stage IV gastric cancer. Laparoscopic gastrectomy with metastasectomy in selected stage IV gastric cancer patients is safe and feasible.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00464-020-07592-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical Management of Gastric Gastrointestinal Stromal Tumors.
Surg Clin North Am
February 2025
Division of Surgical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, East/Shapiro 3, Boston, MA 02215, USA. Electronic address:
Article Synopsis
- Gastrointestinal stromal tumors (GISTs) are a type of sarcoma found in the muscular layer of the gastrointestinal tract, primarily occurring in the stomach and small intestine.
- The main treatment is surgical resection, with various techniques available, though extensive surgical measures like lymphadenectomy are usually not needed.
- Tyrosine kinase inhibitors can be used before surgery to shrink tumors and after surgery for high-risk cases, and in some instances, removing metastases can enhance patient outcomes.
The Role of Metastasectomy in Patients with Liver-Only Metastases from Gastric Adenocarcinoma.
Ann Surg Oncol
January 2025
Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Article Synopsis
- A national registry analysis was conducted to evaluate the impact of different surgical treatments on the survival of patients with gastric adenocarcinoma and liver-only metastases.
- Out of the 10,977 patients studied, those who received both primary tumor resection and liver metastasectomy had the longest median overall survival (OS) of 18.6 months compared to 6.5 months for those with no surgery.
- The results indicate that for selected patients with favorable conditions, surgical intervention may improve survival outcomes significantly compared to not receiving surgery or undergoing single treatment options.
Prognostic Outcome of Pulmonary Resection for Pulmonary Metastases from Gastric Cancer.
Ann Thorac Cardiovasc Surg
June 2024
Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Purpose: Regardless of the devastating outcomes of pulmonary resection for metastases from gastric cancer, a handful of patients survive long after pulmonary metastasectomy. This study aimed to identify a good candidate for pulmonary resection for metastases from gastric cancer.
Methods: Between 2005 and 2023, 564 patients underwent pulmonary metastasectomy in our department, of which 12 patients underwent pulmonary resection for metastases from gastric cancer.
Survival benefits of gastrectomy in patients with metastatic gastric cancer: A meta-analysis.
Adv Clin Exp Med
June 2024
Department of Cardiology, Longgang District People's Hospital of Shenzhen, Guangdong, China.
Background: Individuals with metastatic gastric cancer (MGC) are incurable and have a poor prognosis. To date, surgical resection with curative intent is the only treatment providing hope for a cure, but the role of surgical resection is still controversial.
Objectives: To assess the effects of gastrectomy compared to non-resection on MGC patient survival.
[Long-Term Survival of an Adolescent and Young Adult Patient with Unresectable Advanced Gastric Cancer in Whom Multidisciplinary Treatment Was Effective].
Gan To Kagaku Ryoho
December 2023
Dept. of Surgery, Kochi Medical School.
We report the case of a long-term-surviving adolescent and young adult patient with unresectable advanced gastric cancer for whom multidisciplinary treatment was effective. A 29-year-old woman was referred to our hospital for further examination following a diagnosis of gastric cancer by a local physician. Esophagogastroduodenoscopy showed a deep ulcerated lesion in the lower third of the stomach, and analysis of biopsy specimens revealed an adenocarcinoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!